HTA4Patients

HTA4Patients - Advanced EUPATI Training for Increased Patient Involvement in HTA

Patients will play a vital role in Health Technology Assessments across the EU when the HTA Regulation ((EU) 2021/2282) comes into force in 2025. 

Patients will therefore require access to training, education and information on HTA and the ways in which they can be involved. Over the past 12 years, The European Patients’ Academy on Therapeutic Innovation (EUPATI) has become a key multistakeholder actor for patient engagement in Europe, with an extensive track record in patient education in medicines research and development. EUPATI has become the ‘go to’ portal for independent, user-friendly information on medicines R&D.

In this project EUPATI will address subtopic (a) HS-g-22-20.01 ‘patient experts’ and proposes to:

1.  Update EUPATI’s existing patient training content on HTA aligning with the new Regulation
2.  Design an e-learning training course for patients on HTA and the specific requirements for the new Regulation
3.  Develop interactive online training sessions (in 6 languages) preparing participants to take part in joint clinical assessments and joint scientific consultations with national HTA bodies 
4. Develop and implement sustainability measures to ensure continuity of the project outputs into the future.

This project is in full alignment with EUPATI’s mission to further patient engagement in medicines R&D through education.